Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Vijaya Diagnostic Centre Ltd - IPO Note - YES Securities

Posted On: 2021-09-02 12:55:06 (Time Zone: UTC)


Largest integrated diagnostic chain in South India

Vijaya Diagnostic Centre (VDCL) is one of the largest integrated diagnostic chain in South India, having a dominant market share and brand recall in the Telangana and Andhra Pradesh. After starting in 1981, the company has 81 diagnostic centres in 13 cities / towns. It has 7% share in Telangana and Andhra non-hospital diagnostic market. Promoted by S. Surendranath Reddy, promoters own 60% stake while rest is owned by PE firm Kedaara Capital. After OFS, Kedaara would own 10%.

One of the highest B2C contribution amongst organized chains

Vijaya Diagnostics has the highest B2C revenue with 93% of its revenue coming from B2C segment in FY20. The company has ensured that the focus will remain on building a strong B2C presence in and around the geographies it is present ion along with new geographies it is looking to grow. VDCL's network includes 1 flagship centre, 20 hub centres and 60 diagnostic centres. The company also has 11 reference laboratories (including a national reference laboratory). The 'hub and spoke' model implemented by the company, collects specimens across multiple locations within a catchment area for shipment to their reference laboratories. Since company also offers radiology services across the network, it has higher realisation and tests per patient compared to DLPL and METROHL.

Focus on growing in existing adjacencies and East India

VDCL has a market share of 7% in the organized out of hospitals diagnostic space in Telangana and AP. The management estimates the size of this market to be ~Rs.51bn and Vijaya is well placed to capture a larger piece of this market. The company is focusing on expanding in Tier 1 and 2 cities/towns which is underpenetrated and will help them cater to nearby villages also. VDCL is also looking to expand its footprint in the East India and has acquired Medinova in 2015 which has a good presence in Kolkata. Management reckons East India is largely underpenetrated and has better scope of growth. Company has guided for Rs650mn-750mn capex which will be funded through internal accruals.

Early teens growth in past 2 years with best in class margin

VDCL has delivered 13% CAGR Revenue growth from FY19 to FY21 and is expecting to grow considerably faster than the industry average of 10-12%. EBITDA Margins of ~40% in FY20 are impressive largely a result of the company catering to the B2C segment which is less impacted by pricing erosion compared to B2B sourcing of samples. A new centre breaks even in the quarter of its inception. Strong return ratios coupled with negative working capital due to higher B2C revenues is another positive we like. Promoter owns land housing some of the diagnostic centres and receives rent from company.

Subscribe to a retail-footfalls driven franchise

At a post-issue market cap of Rs54.1bn, OFS is priced at ~64x FY21 P/E. On a forward basis, a steady growth and margin profile would translate in to valuation which would be at a marginal discount or in line with the 55-60x FY23 multiples commanded by DLPL and METROHL. Vijaya owns a retail footfall-driven business which would take time to scale up in newer geographies but then precludes pricing pressure due to lack of a sizable B2B business. We note that other listed peers like DLPL and METROHL have a significant B2B presence. Also, there appears to be a lot of scope to grow market share in existing markets given the large potential. Recommend Subscribe on a medium term basis though cognizant that near term triggers or surprises on growth after a COVID-fueled Q1 FY22 appear unlikely.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.


Other Headlines:

Auto Sector Update - Will EVs impact the 'EV' - Part Deux - HDFC Securities

Automobile Sector - Monthly Quick View - Aug'21 - Mixed Performance across Segments - Reliance Securities

Axis Securities initiating coverage on ICICI Securities

Company Update - Minda Corporation - Q1FY22 - ICICI Direct

Quant Pick - PVR Ltd - ICICI Direct

Quant Pick - ONGC - ICICI Direct

Peak in the headline wholesale inflation is behind us - WPI August 2021 - Acuité Ratings

Sansera Engineering - IPO - Strong Outlook with Steady Cash Flow - Reliance Securities

APL Apollo Tubes - Journey from a semi-commodity player to a branded one - HDFC Securities

Nazara Technologies Ltd - Upbeat in medium-term, Uncertain over Long-term - YES Securities

IPO Review - Sansera Engineering Ltd - ICICI Direct

Overall index is still 0.3% lower than the pre-pandemic levels - IIP July 2021

YES SECURITIES on Monthly General Insurance & Mutual Funds Data

India urban logistics spaces expected to cross 7 million sq. ft by 2022: JLL

Neogen Chemicals - Breaking into the next orbit with a bang - HDFC Securities

Gladiator Stocks - Bharti Airtel Ltd - ICICI Direct

Gladiator Stocks - V-Guard - ICICI Direct

Balkrishna Industries - Industry export growth accelerates - ICICI Securities

HDFC Life Insurance - Exide Life Acquisition - Maintain ADD - YES Securities

Gladiator Stocks - Grindwell Norton - ICICI Direct

Gladiator Stocks - Godrej Properties - ICICI Direct

Monthly Auto Volumes - August 2021 - ICICI Direct

Stock Tales - Easy Trip Planners - ICICI Direct

IPO Review - Vijaya Diagnostic Centre Ltd - ICICI Direct

AU Small Finance Bank - Attrition at top level remains key challenge; business momentum sustained in Jul/Aug'21 - ICICI Securities

Gladiator Stocks - State Bank of India - ICICI Direct

Gladiator Stocks - PNC Infratech - ICICI Direct

Consumer Durables Sector - Lockdown mars performance yet again - Institutional Research Desk at HDFC Securities

75% of the employees today want to be in office at least once a week as compared to 52% in October 2020: JLL

Gladiator Stocks - Safari Industries - ICICI Direct

Gladiator Stocks - Interglobe Aviation - ICICI Direct

IPO Review - Ami Organics Ltd - ICICI Direct

Q1FY22 GDP - 31st Aug 2021 - Acuité Ratings & Research

Avanti Feeds - Higher input prices hurt margins - ICICI Securities

Company Update - Restructuring - Aarti Industries - ICICI Direct

Q1FY22 Company Update - MM Forgings - ICICI Direct

Company Update - Arvind Fashions - ICICI Direct

Zomato - Can margins and multiples surprise? - ICICI Securities

Ujjivan Small Finance Bank - Top management change and lumpy provisioning concern to weigh on valuation in near term - ICICI Securities

Bharat Dynamics - Guided missile systems to drive orderbook and profit growth - ICICI Securities

Economy - Continued accommodation necessary despite inflationary risks: MPC minutes - ICICI Securities

InterGlobe Aviation - Annual report analysis: Liquidity management remains the mainstay in anticipation of traffic recovery - ICICI Securities

General insurance - Health remains dominant growth driver; Strong all-round performance by Bajaj Allianz - ICICI Securities

Earnings Wrap Q1FY22: Resilient earnings, limited impact of second Covid wave - ICICI Direct

Fine Organic Industries Results Review - In-line performance - HDFC Securities

Power Plus Sector Update - July witnessed strong ~10% generation growth - HDFC Securities

Information Technology Sector Update - 'Hit Refresh' - HDFC Securities

Maintain ADD on JK Cement - Healthy performance - HDFC Securities

Maintain BUY on Star Cement - Margin recovers on pricing gain - HDFC Securities

Maintain BUY on Sadbhav Engineering - Long road to recovery - HDFC Securities


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020